Robert A. Bradway is the Chief Executive Officer, Chairman and President of Amgen. Robert has held the CEO seat since May 2012, and was previously Managing Director, London at Morgan Stanley.
Current company
Amgen
Amgen is an American multinational biopharmaceutical company.
pharmaceutical industryHeadquartered in Thousand OaksFounded 1980Nasdaq: AMGN
Source: WikidataRobert A. Bradway joined Amgen in 2006 and has been CEO since May 2012. Before Amgen, Robert was Managing Director, London at Morgan Stanley from 2001 until 2006.
Career
Sources: Amgen Inc 2026 DEF 14A
Education
Amherst CollegeHarvard UniversityHarvard Business SchoolSource
260+ decision makers at Amgen in Unify, vice president level and above. Choose a function to see who leads it.
Top decision makers at Amgen
Vice president level and above, most senior firstRobert A. Bradway leads a leadership team of 10 published executives. The most recent appointment is James E. Bradner as Executive Vice President, Research and Development, in seat since 2023.
Most senior 5 of 10
| Name | Title | In seat since |
|---|---|---|
| Robert A. Bradway | Chairman of the Board, Chief Executive Officer and President | 2012 |
| Peter H. Griffith | Executive Vice President and Chief Financial Officer | 2020 |
| Jonathan P. Graham | Executive Vice President and General Counsel and Secretary | 2019 |
| David M. Reese | Executive Vice President and Chief Technology Officer | 2023 |
| Nancy A. Grygiel | Senior Vice President and Chief Compliance Officer | 2020 |
Sources: Amgen 2025 Form 10-K
Robert A. Bradway is the Chief Executive Officer, Chairman and President of Amgen. Robert has held the CEO seat since May 2012, and was previously Managing Director, London at Morgan Stanley.
Robert A. Bradway has been CEO of Amgen since May 2012, according to Amgen Inc 2026 DEF 14A.
Robert A. Bradway was Managing Director, London at Morgan Stanley from 2001 until 2006, according to Amgen Inc 2026 DEF 14A.
Robert A. Bradway has been CEO of Amgen for 14 years, since May 2012.
Peter H. Griffith (Executive Vice President and Chief Financial Officer), Jonathan P. Graham (Executive Vice President and General Counsel and Secretary), David M. Reese (Executive Vice President and Chief Technology Officer), Nancy A. Grygiel (Senior Vice President and Chief Compliance Officer), and 5 more. Source: Amgen 2025 Form 10-K.
The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.
